Halozyme Therapeutics Inc (NASDAQ:HALO)

Delayed Data
As of Aug 17
 -1.08 / -2.43%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 53.00, with a high estimate of 63.00 and a low estimate of 21.00. The median estimate represents a +22.12% increase from the last price of 43.40.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 102.08%
Growthannually -50.55%


Growthquarterly 24.52%
Growthannually 50.86%
Key to the earnings and sales forecast charts.